Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027709
Filing Date
2024-11-26
Accepted
2024-11-26 16:15:07
Documents
1
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 form4-11262024_041101.html 4  
1 form4-11262024_041101.xml 4 20994
  Complete submission text file 0001415889-24-027709.txt   22437
Mailing Address 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA 22902
Business Address
Manning Paul B (Reporting) CIK: 0001494695 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 241503947

Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)